Financial Consulate, Inc Adma Biologics, Inc. Transaction History
Financial Consulate, Inc
- $678 Million
- Q3 2025
A detailed history of Financial Consulate, Inc transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Financial Consulate, Inc holds 3,000 shares of ADMA stock, worth $47,100. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,000Holding current value
$47,100% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding ADMA
# of Institutions
389Shares Held
196MCall Options Held
2.11MPut Options Held
1.56M-
Vanguard Group Inc Valley Forge, PA21MShares$329 Million0.0% of portfolio
-
Black Rock Inc. New York, NY18.6MShares$293 Million0.0% of portfolio
-
State Street Corp Boston, MA13.6MShares$213 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.5MShares$196 Million0.03% of portfolio
-
Geode Capital Management, LLC Boston, MA5.81MShares$91.3 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.08B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...